Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial.
作者信息
Aniwan Satimai
机构信息
Gastrointestinal Endoscopy Excellence Center, Division of Gastroenterology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
出版信息
Clin Endosc. 2022 Mar;55(2):210-212. doi: 10.5946/ce.2022.063. Epub 2022 Mar 14.
Abstract
摘要
相似文献
1
Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial.粪便钙卫蛋白作为启动抗结核治疗试验后黏膜愈合的替代标志物。
Clin Endosc. 2022 Mar;55(2):210-212. doi: 10.5946/ce.2022.063. Epub 2022 Mar 14.
2
Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis.粪便钙卫蛋白：活动性溃疡性结肠炎治疗后黏膜愈合的可靠预测指标。
Gastroenterol Res Pract. 2017;2017:2098293. doi: 10.1155/2017/2098293. Epub 2017 Oct 31.
3
Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial.治疗性抗结核试验初期粪便钙卫蛋白检测的价值
Clin Endosc. 2022 Mar;55(2):256-262. doi: 10.5946/ce.2021.061. Epub 2021 Nov 5.
4
Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin.利用粪便钙卫蛋白预测克罗恩病内镜活动和黏膜愈合的准确临界值。
Rev Esp Enferm Dig. 2017 Feb;109(2):130-136. doi: 10.17235/reed.2017.4542/2016.
5
Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease.粪便钙卫蛋白、乳铁蛋白与内镜下疾病活动度在监测克罗恩病抗TNF-α治疗中的作用
Inflamm Bowel Dis. 2008 Oct;14(10):1392-8. doi: 10.1002/ibd.20490.
6
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.粪便钙卫蛋白评估溃疡性结肠炎患者内镜和组织学缓解的价值。
Dig Dis Sci. 2018 May;63(5):1294-1301. doi: 10.1007/s10620-018-4980-0. Epub 2018 Feb 22.
7
Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn's Disease.黏膜和透壁愈合与儿童克罗恩病粪便钙卫蛋白水平的相关性。
Clin Gastroenterol Hepatol. 2018 Jul;16(7):1089-1097.e4. doi: 10.1016/j.cgh.2018.01.024. Epub 2018 Mar 2.
8
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.粪便钙卫蛋白是炎症性肠病内镜下病变的替代标志物。
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24. doi: 10.1002/ibd.22917. Epub 2012 Feb 16.
9
Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels.英夫利昔单抗迅速降低小儿炎症性肠病患者粪便钙卫蛋白水平。
World J Gastroenterol. 2011 Dec 21;17(47):5166-71. doi: 10.3748/wjg.v17.i47.5166.
10
Noninvasive evaluation of mucosal healing in inflammatory bowel diseases.炎症性肠病黏膜愈合的非侵入性评估
Clin J Gastroenterol. 2013 Feb;6(1):1-7. doi: 10.1007/s12328-012-0346-x. Epub 2012 Nov 28.
本文引用的文献
1
Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial.治疗性抗结核试验初期粪便钙卫蛋白检测的价值
Clin Endosc. 2022 Mar;55(2):256-262. doi: 10.5946/ce.2021.061. Epub 2021 Nov 5.
2
Development and validation of a new algorithm model for differential diagnosis between Crohn's disease and intestinal tuberculosis: a combination of laboratory, imaging and endoscopic characteristics.开发和验证一种新的克罗恩病和肠结核鉴别诊断算法模型：实验室、影像学和内镜特征的联合。
BMC Gastroenterol. 2021 Jul 13;21(1):291. doi: 10.1186/s12876-021-01838-x.
3
Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: A multicenter study from Asia.采用基本参数对肠道结核与克罗恩病进行模型验证：亚洲多中心研究。
PLoS One. 2020 Nov 30;15(11):e0242879. doi: 10.1371/journal.pone.0242879. eCollection 2020.
4
Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn's disease in patients started on antitubercular therapy.开始抗结核治疗的患者粪便钙卫蛋白的连续测量可用于鉴别肠结核和克罗恩病。
Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):334-338. doi: 10.1097/MEG.0000000000001879.
5
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia.亚洲克罗恩病和结肠炎组织与亚太消化病学会炎症性肠病亚洲地区医学管理和监测实践建议。
J Gastroenterol Hepatol. 2021 Mar;36(3):637-645. doi: 10.1111/jgh.15185. Epub 2020 Jul 29.
6
Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn's disease in patients with positive results.结核感染T细胞检测（TB-IGRA）水平可能有助于鉴别检测结果呈阳性的患者是患肠结核还是克罗恩病。
Therap Adv Gastroenterol. 2020 May 18;13:1756284820922003. doi: 10.1177/1756284820922003. eCollection 2020.
7
Intestinal tuberculosis or Crohn's disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases.肠结核或克罗恩病：旨在区分这两种胃肠道疾病的诊断模型综述
Intest Res. 2021 Jan;19(1):21-32. doi: 10.5217/ir.2019.09142. Epub 2020 Apr 22.
8
Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.用于区分肠结核和克罗恩病的Meta分析贝叶斯模型
Am J Gastroenterol. 2017 Mar;112(3):415-427. doi: 10.1038/ajg.2016.529. Epub 2017 Jan 3.
9
[A Meta-analysis of the accuracy of interferon-γ release assays in differentiating intestinal tuberculosis from Crohn's disease in Asia].[亚洲地区干扰素-γ释放试验鉴别肠结核与克罗恩病准确性的Meta分析]
Zhonghua Nei Ke Za Zhi. 2016 Jul 1;55(7):535-40. doi: 10.3760/cma.j.issn.0578-1426.2016.07.010.
10
Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn's disease.组织病理学和 TB-PCR 试剂盒分析在鉴别诊断肠结核和克罗恩病中的作用。
World J Gastroenterol. 2010 May 28;16(20):2496-503. doi: 10.3748/wjg.v16.i20.2496.
Zotero 插件